Research study Program year 2022 Source: CMS Open Payments

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

Research payments

$1,064,932

984 payments

Through program year 2022, $1,064,932 in research payments was reported against A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis, across 984 payments, paid by Incyte Corporation.

Paid by: Incyte Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$1,045,932	979
2021	Research	$19,000	5

Breakdown

Who paid Research payments · program years 2021–2022

Incyte Corporation $1,064,932 984 payments

Who received the money Research payments · program years 2021–2022

Revival Research Institute, LLC Troy Organisation paid for research $154,858 63 payments
Medical Dermatology Specialists Phoenix Organisation paid for research $80,206 64 payments
Fxm Research Corporation Miramar Organisation paid for research $71,028 83 payments
Activmed Practices And Research INC Organisation paid for research $69,874 55 payments
The South Bend Clinic Main Campus Organisation paid for research $66,082 46 payments
Aventiv Research INC-Dublin Organisation paid for research $63,726 33 payments
Fxm Research Corporation Fort Lauderdale Organisation paid for research $62,822 71 payments
Olympian Clinical Research Organisation paid for research $55,379 83 payments
Arlington Research Center Organisation paid for research $53,954 55 payments
Medisearch Clinical Trials Organisation paid for research $51,543 11 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.